FI54912C - Foerfarande foer framstaellning av nya beta-aryl-2-aminoalkoxystyroler - Google Patents

Foerfarande foer framstaellning av nya beta-aryl-2-aminoalkoxystyroler

Info

Publication number
FI54912C
FI54912C FI2035/70A FI203570A FI54912C FI 54912 C FI54912 C FI 54912C FI 2035/70 A FI2035/70 A FI 2035/70A FI 203570 A FI203570 A FI 203570A FI 54912 C FI54912 C FI 54912C
Authority
FI
Finland
Prior art keywords
aminoalcoxystyroler
nya
beta
aryl
frequency requirement
Prior art date
Application number
FI2035/70A
Other languages
English (en)
Finnish (fi)
Other versions
FI54912B (fi
Inventor
Erich Mueller
Roland Maier
Willi Diederen
Original Assignee
Thomae Gmbh Dr K
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Thomae Gmbh Dr K filed Critical Thomae Gmbh Dr K
Application granted granted Critical
Publication of FI54912B publication Critical patent/FI54912B/fi
Publication of FI54912C publication Critical patent/FI54912C/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/28—Radicals substituted by singly-bound oxygen or sulphur atoms
    • C07D213/30—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C37/00—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom of a six-membered aromatic ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C39/00—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring
    • C07C39/18—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring monocyclic with unsaturation outside the aromatic ring
    • C07C39/19—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring monocyclic with unsaturation outside the aromatic ring containing carbon-to-carbon double bonds but no carbon-to-carbon triple bonds
    • C07C39/20—Hydroxy-styrenes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/12—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D215/14—Radicals substituted by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/26—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/10—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D241/12—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
    • C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
    • C07D261/08—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D271/00—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
    • C07D271/02—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
    • C07D271/06—1,2,4-Oxadiazoles; Hydrogenated 1,2,4-oxadiazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/40—Radicals substituted by oxygen atoms
    • C07D307/42—Singly bound oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/14—Radicals substituted by singly bound hetero atoms other than halogen
    • C07D333/16—Radicals substituted by singly bound hetero atoms other than halogen by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/40—Esters thereof
    • C07F9/4003—Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/4056—Esters of arylalkanephosphonic acids

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Molecular Biology (AREA)
  • Anesthesiology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Biochemistry (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Quinoline Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Furan Compounds (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Illuminated Signs And Luminous Advertising (AREA)
FI2035/70A 1969-08-05 1970-07-21 Foerfarande foer framstaellning av nya beta-aryl-2-aminoalkoxystyroler FI54912C (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE1939809A DE1939809B2 (de) 1969-08-05 1969-08-05 ß-Aryl-2-aminoalkoxy-styrole und Verfahren zu ihrer Herstellung

Publications (2)

Publication Number Publication Date
FI54912B FI54912B (fi) 1978-12-29
FI54912C true FI54912C (fi) 1979-04-10

Family

ID=5741970

Family Applications (1)

Application Number Title Priority Date Filing Date
FI2035/70A FI54912C (fi) 1969-08-05 1970-07-21 Foerfarande foer framstaellning av nya beta-aryl-2-aminoalkoxystyroler

Country Status (25)

Country Link
JP (6) JPS4941433B1 (es)
KR (1) KR780000113B1 (es)
AT (5) AT302346B (es)
BE (1) BE754405A (es)
BG (6) BG18600A3 (es)
CH (6) CH548367A (es)
CS (6) CS170535B2 (es)
DE (1) DE1939809B2 (es)
DK (1) DK139717B (es)
ES (6) ES382425A1 (es)
FI (1) FI54912C (es)
FR (1) FR2068463B1 (es)
GB (1) GB1307436A (es)
HU (1) HU163185B (es)
IE (1) IE34634B1 (es)
IL (1) IL35047A (es)
NL (1) NL7011590A (es)
NO (1) NO135243C (es)
PH (1) PH9520A (es)
PL (2) PL93130B1 (es)
RO (5) RO57548A (es)
SE (1) SE382211B (es)
SU (3) SU432712A3 (es)
YU (2) YU198170A (es)
ZA (1) ZA705411B (es)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS50139537A (es) * 1974-04-25 1975-11-07
US4220603A (en) * 1977-10-07 1980-09-02 Mitsubishi Chemical Industries, Limited Pharmaceutically active (omega-aminoalkoxy)bibenzyls
JPS6045632B2 (ja) * 1978-03-09 1985-10-11 三菱化学株式会社 ω−アミノアルコキシスチルベン類及びその酸付加塩
DE2818765A1 (de) 1978-04-28 1979-11-08 Basf Ag Aminoderivate des 2-methyl-5-(2-hydroxystyrol)-1,3,4-thiadiazols
DE2818998A1 (de) * 1978-04-29 1979-11-15 Basf Ag 3-alkyl-5-(2-hydroxy-styryl)-isoxazole und verfahren zu ihrer herstellung
DE2818999A1 (de) * 1978-04-29 1979-11-15 Basf Ag Aminoderivate von 3-alkyl-5-(2- hydroxystyryl)-isoxazolen
JPS5629548A (en) * 1979-08-16 1981-03-24 Mitsubishi Chem Ind Ltd Omega-aminoalkoxystilbenes and their acid addition salts
DE2943405A1 (de) 1979-10-26 1981-05-07 Basf Ag, 6700 Ludwigshafen Neue aminoderivate des 5-(2-hydroxystyryl)-isoxazols
DE2943406A1 (de) 1979-10-26 1981-05-07 Basf Ag, 6700 Ludwigshafen Aminoderivate des 2-methyl-5-(2-hydroxystyryl)-1,3,4-thiadiazols
DE3006809A1 (de) * 1980-02-23 1981-09-24 Basf Ag, 6700 Ludwigshafen 2-((3-amino-2-hydroxy-propoxy)-styryl)-isoxazole, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zubereitungen
JPS5874379U (ja) * 1981-11-16 1983-05-19 富士通株式会社 電子装置
NO174506B (no) * 1984-10-30 1994-02-07 Usv Pharma Corp Analogifremgangsmaate ved fremstilling av terapeutisk aktive forbindelser
BR112013030599A2 (pt) 2011-06-10 2016-09-27 Procter & Gamble núcleo absorvente para artigos absorventes descartáveis
US9468566B2 (en) 2011-06-10 2016-10-18 The Procter & Gamble Company Absorbent structure for absorbent articles
JP2014515983A (ja) 2011-06-10 2014-07-07 ザ プロクター アンド ギャンブル カンパニー 使い捨ておむつ
EP2740449B1 (en) 2012-12-10 2019-01-23 The Procter & Gamble Company Absorbent article with high absorbent material content
PL3254656T3 (pl) 2013-06-14 2022-01-10 The Procter & Gamble Company Wyrób chłonny i wkład chłonny tworzący kanały w stanie mokrym
US9987176B2 (en) 2013-08-27 2018-06-05 The Procter & Gamble Company Absorbent articles with channels
EP3351225B1 (en) 2013-09-19 2021-12-29 The Procter & Gamble Company Absorbent cores having material free areas
EP2886092B1 (en) 2013-12-19 2016-09-14 The Procter and Gamble Company Absorbent cores having channel-forming areas and c-wrap seals

Also Published As

Publication number Publication date
AT301565B (de) 1972-09-11
BG20095A3 (bg) 1975-10-30
ZA705411B (en) 1971-05-27
DE1939809C3 (es) 1979-01-11
JPS5113147B1 (es) 1976-04-26
BG18599A3 (bg) 1975-02-25
BG17952A3 (bg) 1974-03-05
ES382428A1 (es) 1972-11-16
CH548982A (de) 1974-05-15
PL93130B1 (es) 1977-05-30
CS170534B2 (es) 1976-08-27
YU37478A (en) 1979-07-10
NL7011590A (es) 1971-02-09
BG17951A3 (bg) 1974-03-05
ES382426A1 (es) 1972-11-16
SE382211B (sv) 1976-01-19
AT302346B (de) 1972-10-10
FR2068463A1 (es) 1971-08-27
CS170533B2 (es) 1976-08-27
SU439966A3 (ru) 1974-08-15
PL78370B1 (es) 1975-06-30
FR2068463B1 (es) 1974-08-30
CH548367A (de) 1974-04-30
YU198170A (en) 1979-07-10
NO135243B (es) 1976-11-29
BE754405A (fr) 1971-02-04
CH548981A (de) 1974-05-15
AT303055B (de) 1972-11-10
BG18600A3 (bg) 1975-02-25
CH548366A (de) 1974-04-30
SU439965A3 (ru) 1974-08-15
BG17950A3 (bg) 1974-03-05
RO58837A (es) 1975-09-15
SU428597A3 (ru) 1974-05-15
HU163185B (es) 1973-06-28
RO57794A (es) 1975-06-15
KR780000113B1 (en) 1978-04-15
IE34634B1 (en) 1975-07-09
SU450398A3 (ru) 1974-11-15
DK139717C (es) 1979-09-17
JPS5113146B1 (es) 1976-04-26
CS170535B2 (es) 1976-08-27
JPS5113149B1 (es) 1976-04-26
DE1939809A1 (de) 1971-02-18
CS170537B2 (es) 1976-08-27
RO58861A2 (ro) 1975-06-30
CH548368A (de) 1974-04-30
AT302344B (de) 1972-10-10
RO57548A (es) 1975-02-15
FI54912B (fi) 1978-12-29
RO57793A (es) 1975-03-15
IL35047A0 (en) 1970-10-30
ES382425A1 (es) 1972-11-16
ES382429A1 (es) 1972-11-16
DE1939809B2 (de) 1978-04-13
DK139717B (da) 1979-04-02
CS170538B2 (es) 1976-08-27
PH9520A (en) 1976-01-09
AT302345B (de) 1972-10-10
JPS5113150B1 (es) 1976-04-26
GB1307436A (en) 1973-02-21
ES382427A1 (es) 1972-11-16
JPS5113148B1 (es) 1976-04-26
SU432712A3 (es) 1974-06-15
IL35047A (en) 1973-05-31
CH548983A (de) 1974-05-15
CS170536B2 (es) 1976-08-27
IE34634L (en) 1971-02-05
NO135243C (es) 1977-03-09
ES382430A1 (es) 1972-12-01
JPS4941433B1 (es) 1974-11-08

Similar Documents

Publication Publication Date Title
FI54912C (fi) Foerfarande foer framstaellning av nya beta-aryl-2-aminoalkoxystyroler
FI53673C (fi) Foerfarande foer framstaellning av kompoundstycken
SE390736B (sv) Forfarande for framstellning av maltos
FI53810B (fi) Foerfarande foer avfaergning av avloppsvaetska fraon cellulosablekning
FI54593C (fi) Nya cementblandningar
FI53456C (fi) Foerfarande foer framstaellning av nya terapeutiskt aktiva isoindolinderivat
FI53897C (fi) Ljuskaensliga foereningar och foerfarande foer framstaellning av dessa
SE415758B (sv) Forfarande for framstellning av nya substituerade n-aminoalkylarylamino-imidazoliner-(2)
FI53573C (fi) Foerfarande foer framstaellning av kinoxalin-di-n-oxider
FI55029B (fi) Foerfarande foer framstaellning av nya terapeutiskt aktiva isoindolinderivat
FI53669C (fi) Skaerhuvud foer profilspaonskaerning av rundvirke
FI53941B (fi) Anordning foer resning av kartonger
FI53814C (fi) Foerfarande foer framstaellning av nya tuberkulostatiskt verkande alfa-aminoxikarbonyl-hydroxamsyra-derivat
FI55198C (fi) Foerfarande foer framstaellning av nya terapeutiskt aktiva isoindolinderivat
FI54038C (fi) Anordning foer beskiktning av en fiberslang
SE383631B (sv) Forfarande for framstellning av nya 1-fenoxi-2-hydroxid-3-hydroxialkylaminopropaner
FI46520B (fi) Foerfarande foer attenuering av kalvdiarre-virus
FI53453C (fi) Foerfarande foer framstaellning av cytostatiskt verksamma nya sykloalifatiska difunktionella kvaevehaltiga sulfonsyraestrar
FI56008B (fi) Foerfarande foer framstaellning av nya terapeutiskt verksamma en o-sulfobenzoesyraimidgrupp innehaollande piperidoner
FI53467C (fi) Foerfarande foer framstaellning av bundna fiberskivor
FI53305C (fi) Foerfarande foer framstaellning av nya hepta- och oktapeptider
FI54480C (fi) Foerfarande foer framstaellning av nya blodtryckssaenkande substituerade 3-amino-4-halogen-sydnon-iminer
FI54117C (fi) Foerfarande foer framstaellning av nya koronardilatatoriskt verkande substituerade 7-ureidocumarinderivat
FI53816C (fi) Foerfarande foer framstaellning av nya n n -diacylhydrazinderivat foer foerhindrande av tuberkulos
FI53727C (fi) Foerfarande foer tillvaratagande av cellulosakokkemikalier